The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

1 Jun 2017 15:43

RNS Number : 9125G
Georgia Healthcare Group PLC
01 June 2017
 

  London, 1 June 2017

 

 

Georgia Healthcare Group PLC - Result of AGM

 

 

The Board of Directors of Georgia Healthcare Group PLC (the "Company") announces the results of voting on the resolutions put to shareholders at its Annual General Meeting (the "AGM") held on Thursday, 1 June 2017. Details of the resolutions are set out in full in the Notice of AGM dated 2 May 2017.

 

 

In line with the proposal to amend resolution 6 (to elect Neil Janin as a Non-Executive Director) set out in the announcement made by the Company on 30 May 2017 (the "Announcement"), the Chairman made a motion to amend resolution 6 (to elect Neil Janin as a Non-Executive Director) so as to elect Mr Janin as a non-independent Non-Executive Director. This motion was approved by the meeting on a show of hands and accordingly, resolution 6 was duly amended as described in the Announcement.

 

 

Resolutions 1 to 14 were passed as ordinary resolutions and resolutions 15, 16 and 17 were passed as special resolutions. As the Company has a controlling shareholder, BGEO Group PLC, as defined in the Financial Conduct Authority's Listing Rules, each resolution to elect an independent Non-Executive Director (resolutions 5 and 7 to 10) has been approved by a majority of the votes cast by:

· the shareholders of the Company as a whole; and

· the independent shareholders of the Company, that is, all the shareholders entitled to vote on each resolution excluding the controlling shareholder.

 

 

The results of the poll were as follows:

 

RESOLUTION

VOTESFOR

%

VOTES AGAINST

%

VOTESTOTAL

% OF TOTAL ISC* VOTED

VOTES WITHHELD

1 To receive and adopt the Annual Report and Accounts for the year ended 31 December 2016.

 

125,778,315

 

99.86

 

173,400

 

0.14

 

125,951,715

95.65

0

2 To receive and approve the Director's Remuneration Report for the year ended 31 December 2016.

119,540,079

94.91

6,411,635

5.09

125,951,714

95.65

0

3 To re-elect Irakli Gilauri, as Non-Executive Director of the Company.

115,516,288

99.37

726,592

0.63

116,242,880

88.28

9,708,833

4 To re-elect Nikoloz Gamkrelidze, as an Executive Director.

125,951,715

100.00

0

0.0

125,951,715

95.65

0

5** To re-elect David Morrison, as a Non-Executive Director.

125,597,507

99.72

354,207

0.28

125,951,714

95.65

0

6 To re-elect Neil Janin, as a Non-Executive Director.

101,206,107

88.21

13,524,591

11.79

114,730,698

87.13

11,221,016

7** To re-elect Ingeborg Oie, as a Non-Executive Director.

125,951,715

100.00

0

0.00

125,951,715

95.65

0

8** To re-elect Tim Elsigood, as a Non-Executive Director.

125,951,715

100.00

0

0.00

125,951,715

95.65

0

9** To re-elect Mike Anderson, as a Non-Executive Director.

125,951,715

100.00

0

0.00

125,951,715

95.65

0

10** To re-elect Jacques Richier, as a Non-Executive Director.

107,564,380

85.56

18,158,106

14.44

125,722,486

95.47

229,229

11 To re-appoint Ernst & Young LLP as Auditor of the Company.

125,776,019

100.00

0

0.00

125,776,019

95.52

175,695

12 To authorise the Board to set the remuneration of the Auditor.

125,951,715

100.00

0

0.00

125,951,715

95.65

0

13 To authorise political donations and political expenditure.

125,467,708

99.75

308,311

0.25

125,776,019

95.52

175,695

14 To authorise the Board to allot shares.

125,738,515

99.83

213,200

0.17

125,951,715

95.65

0

15 To authorise the disapplication of pre-emption rights.

125,638,354

99.75

313,361

0.25

125,951,715

95.65

0

16 To authorise the disapplication of pre-emption rights for the purposes of acquisitions or capital investments.

125,307,546

99.49

644,168

0.51

125,951,714

95.65

0

17 To authorise the Company to purchase its own shares.

125,770,907

99.86

180,807

0.14

125,951,714

95.65

0

*Issued share capital

**Independent Director

 

 

 

 

Votes of independent shareholders on the resolutions concerning the re-election of the independent Non-Executive Directors

RESOLUTION

VOTESFOR

%

VOTES AGAINST

%

VOTESTOTAL

% OF TOTAL ISC* VOTED

VOTES WITHHELD

5** To re-elect David Morrison, as a Non-Executive Director.

46,442,484

99.24

354,207

0.76

46,796,691

89.09

0

7 **To re-elect Ingeborg Oie, as a Non-Executive Director.

46,796,692

100.00

0

0.00

46,796,692

89.09

0

8 *\* To re-elect Tim Elsigood, as a Non-Executive Director.

46,796,692

100.00

0

0.00

46,796,692

89.09

0

9 *\* To re-elect Mike Anderson, as a Non-Executive Director.

46,796,692

100.00

0

0.00

46,796,692

89.09

0

10**To re-elect Jacques Richier, as a Non-Executive Director.

28,409,357

61.01

18,158,106

38.99

46,567,463

88.65

229,229

*Issued share capital

**Independent Director

 

 

The Board notes the level of votes against the re-election of Jacques Richier, an independent Non-Executive Director, which the Board understands reflects certain investors' views on Mr Richier's record of attendance at Board meetings in 2016. The Board acknowledges the feedback and also notes the contribution Mr Richier made outside Board meetings in 2016 including engaging with management, and, as stated in the 2016 Annual Report, the Board has concluded that Mr. Richier continues to act as an effective independent Non-Executive Director. Mr Richier is dedicated to improving his attendance in 2017 and we will continue to engage with shareholders on this and all matters of Board governance.

 

As at the date of the AGM, the Company had 131,681,820 ordinary shares in issue. The Company did not hold any shares in treasury and therefore the number of total voting rights as at the date of the AGM was 131,681,820. In accordance with the Company's Articles of Association and subject to the Listing Rules, on a poll every member who is present in person or by proxy has one vote for every share held. The scrutineer of the poll was Computershare Investor Services PLC, the Company's Share Registrar.

 

Note that a "vote withheld" is not a vote in law and such votes have not been included in the calculation of votes "for" and "against" each resolution. Proxy appointments which gave discretion to the Chairman have been included in the "for" total above.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions which constitute special business at the AGM (being resolutions 14 to 17) will be submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

 

A copy of this announcement has been posted on the Company's website ghg.com.ge.

 

 

 

Rebecca Wooldridge, on behalf of Sirius Compliance Solutions Ltd, Company Secretary

 

 

 

 

 

 

 

 

 

 

 

About Georgia Healthcare Group PLC

Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 35 hospitals and ten ambulatory clusters (consisting of 13 district ambulatory clinics and 28 express ambulatory clinics), as at 31 March 2017. GHG is the single largest market participant, accounting for 23.4% of total hospital bed capacity in the country, as of 31 March 2017. From January 2017, GHG become the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 29% market share based on 31 December 2015 revenue figures. GHG is also the largest provider of medical insurance in Georgia with a 35.3% market share based on net insurance premiums earned and approximately 135,000 insurance customers as at 31 March 2017. GHG employed a total of c.14,600 people as at 31 March 2017, including c.3,300 physicians.

 

For further information, please visit www.ghg.com.ge or contact: 

Nikoloz Gamkrelidze

Irakli Gogia

Ekaterina (Eka) Shavgulidze

CEO

CFO

Head of Investor Relations

+995 322 550505 (5077)

+995 322 550505 (5088)

+995 322 444 205

ngamkrelidze@ghg.com.ge

irakligogia@ghg.com.ge

ir@ghg.com.ge

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGUASSRBOANRAR
Date   Source Headline
23rd Aug 20187:30 amRNSUpdate on Georgia Capital's holding in GHG
15th Aug 20187:00 amRNSHalf-year Report
9th Aug 20187:00 amRNSNotice of Results
25th Jul 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20184:41 pmRNSSecond Price Monitoring Extn
23rd Jul 20184:35 pmRNSPrice Monitoring Extension
12th Jul 20187:00 amRNSGHG has launched a new Home Care service
2nd Jul 201812:26 pmRNSDirector/PDMR Shareholding
28th Jun 20185:02 pmRNSDirector/PDMR Shareholding
21st Jun 20183:13 pmRNSDirector/PDMR Shareholding
20th Jun 20185:00 pmRNSDirector/PDMR Shareholding
15th Jun 201811:57 amRNSDirector/PDMR Shareholding
12th Jun 20182:56 pmRNSDirector/PDMR Shareholding
6th Jun 20185:20 pmRNSDirector/PDMR Shareholding
29th May 20188:43 amRNSHolding(s) in Company
24th May 201812:04 pmRNSDirector/PDMR Shareholding
17th May 201810:18 amRNSDirector/PDMR Shareholding
15th May 20187:03 amRNS1st Quarter Results
11th May 20187:00 amRNSNotice of Results
30th Apr 20181:23 pmRNSResult of AGM
23rd Apr 20184:35 pmRNSPrice Monitoring Extension
20th Apr 20184:40 pmRNSSecond Price Monitoring Extn
20th Apr 20184:35 pmRNSPrice Monitoring Extension
29th Mar 20184:42 pmRNSDirector/PDMR Shareholding
26th Mar 20184:37 pmRNSNotice of AGM
26th Mar 20182:12 pmRNSDirector/PDMR Shareholding
19th Mar 20184:35 pmRNSPrice Monitoring Extension
19th Mar 201812:04 pmRNSDirector/PDMR Shareholding
15th Mar 201812:15 pmRNSDirector/PDMR Shareholding
12th Mar 20182:07 pmRNSDirector/PDMR Shareholding
8th Mar 20187:30 amRNSDirector/PDMR Shareholding
8th Mar 20187:00 amRNSGHG launches a new district polyclinic in Tbilisi
7th Mar 20187:00 amRNSAnnual Financial Report
5th Mar 20187:30 amRNSDirector/PDMR Shareholding
2nd Mar 20187:30 amRNSDirector/PDMR Shareholding
27th Feb 20187:30 amRNSDirector/PDMR Shareholding
23rd Feb 20185:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20187:30 amRNSDirector/PDMR Shareholding
15th Feb 20187:00 amRNSFinal Results
12th Feb 20187:00 amRNSNotice of Results
26th Jan 20187:00 amRNSAcquisition of a new medical insurance client
27th Dec 20177:00 amRNSGHG acquired a district Polyclinic in Tbilisi
5th Dec 20174:40 pmRNSSecond Price Monitoring Extn
5th Dec 20174:35 pmRNSPrice Monitoring Extension
9th Nov 20175:00 pmRNSGHG hosts Investor Day in Tbilisi
9th Nov 20177:00 amRNSGHG acquired a district Polyclinic in Tbilisi
8th Nov 20177:00 amRNS3rd Quarter Results
6th Nov 20177:00 amRNSNotice of Results
3rd Nov 20174:35 pmRNSPrice Monitoring Extension
3rd Nov 20177:00 amRNSGHG launches an oncology inpatient department

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.